Byung-wan W. Lee-Wan
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Standardizing the Accuracy and Performance Evaluation Metrics of Integrated Continuous Glucose Monitors in the Asia-Pacific Region.
Journal: Diabetes technology & therapeutics
Published: February 06, 2026
Protective Role of Serum β-Hydroxybutyrate in Early Diabetic Kidney Disease: A Longitudinal Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 01, 2025
Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3.
Journal: Diabetes, obesity & metabolism
Published: March 06, 2025
Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.
Journal: Kidney diseases (Basel, Switzerland)
Published: July 11, 2024
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
Journal: Clinical therapeutics
Published: January 09, 2024
Association between serum beta-hydroxybutyrate levels and risk of type 2 diabetes mellitus in patients with impaired fasting glucose.
Journal: Nutrition & diabetes
Published: November 13, 2023
Dysregulation of autophagy activation induced by atorvastatin contributes to new-onset diabetes mellitus in western diet-fed mice.
Journal: Metabolism: clinical and experimental
Published: October 16, 2023
Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: A randomised trial.
Journal: Diabetes research and clinical practice
Published: June 19, 2023
Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION).
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: February 22, 2023
Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing Study.
Journal: Diabetes & metabolism journal
Published: February 03, 2023
Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 30, 2023
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial.
Journal: Nature medicine
Published: November 10, 2022
Last Updated: 09/26/2026